MDMA.CN
Pharmala Biotech Holdings Inc
Price:  
0.25 
CAD
Volume:  
509,325.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDMA.CN WACC - Weighted Average Cost of Capital

The WACC of Pharmala Biotech Holdings Inc (MDMA.CN) is 13.2%.

The Cost of Equity of Pharmala Biotech Holdings Inc (MDMA.CN) is 22.70%.
The Cost of Debt of Pharmala Biotech Holdings Inc (MDMA.CN) is 5.00%.

Range Selected
Cost of equity 20.50% - 24.90% 22.70%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 12.1% - 14.3% 13.2%
WACC

MDMA.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 3.4 3.4
Additional risk adjustments 0.0% 0.5%
Cost of equity 20.50% 24.90%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 12.1% 14.3%
Selected WACC 13.2%